GATA5 CpG Island Hypermethylation Is an Independent Predictor for Poor Clinical Outcome in Renal Cell Carcinoma

Oncology Reports - Greece
doi 10.3892/or.2014.3030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer

Cancer Management and Research
Oncology
2019English

PON1 Hypermethylation Is Associated With Progression of Renal Cell Carcinoma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Differential Targets of CpG Island Hypermethylation in Primary and Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Journal of Medical Genetics
Genetics
2003English

Simultaneous CXCL12 and ESR1 CpG Island Hypermethylation Correlates With Poor Prognosis in Sporadic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Pretherapeutic Gamma-Glutamyltransferase Is an Independent Prognostic Factor for Patients With Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2014English

Preoperative Nutritional Status Is an Important Predictor of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma

European Urology
Urology
2011English

Epigenetic Inactivation of EGFR by CpG Island Hypermethylation in Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Low Level of PDZ Domain Containing 1 (PDZK1) Predicts Poor Clinical Outcome in Patients With Clear Cell Renal Cell Carcinoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy